VA Boston Health Care System, Boston, MA, USA.
VA Boston Health Care System, Osteoporosis Prevention and Treatment Clinic, Boston, MA, USA.
Osteoporos Int. 2021 Oct;32(10):2051-2059. doi: 10.1007/s00198-021-05926-2. Epub 2021 Apr 6.
People with epilepsy who take certain medications are at risk for developing osteoporosis and fractures of the vertebrae that commonly go undiagnosed. By using technology available in a bone density scan, we observed at least one fracture in many subjects with bone density in the normal and osteopenic range.
PURPOSE/INTRODUCTION: Chronic use of antiepileptic drugs (AEDs), both enzyme-inducing (phenytoin, phenobarbital, carbamazepine, and primidone) and non-enzyme-inducing (i.e., valproate), is recognized as a cause of secondary osteoporosis. Vertebral compression fractures (VF) are the most common type of osteoporotic fractures and may confer an increased risk of future hip, wrist, and vertebral fractures. Vertebral compression fractures in the general population are frequently asymptomatic, and under-diagnosed. The purpose of this study is to describe the prevalence of VF in a cohort of male veterans with epilepsy on chronic AEDs.
The cohort for this study consisted of 146 male veterans who carried a diagnosis of epilepsy and were chronic users of AEDs known to cause osteoporosis (phenobarbital, phenytoin, carbamazepine, primidone, and valproate). Chronic AED use was defined as receiving an AED for at least 2 years. Subjects were previously seen in the osteoporosis clinic and had been evaluated by a dual-energy X-Ray absormetry (DXA) instrument including morphometric studies following a standard vertebral fracture assessment (VFA) protocol during the same DXA imaging acquisition session.
The mean age was 63 years. Low bone mineral density defined as osteoporosis or osteopenia was observed in 29% and 43% respectively. We observed at least one VF in 41 % of the subjects who had normal BMD, 54% in the osteopenic range, and 75% in the osteoporotic range.
By performing a VFA in addition to standard bone densitometric studies, we disclosed a large prevalence of compression fractures in individuals with epilepsy chronically treated with AEDs who had BMDs in the normal and osteopenic ranges. The addition of VFA or other imaging methods to evaluate VF should be included in the evaluation of bone health in individuals with epilepsy receiving AEDs since it may modify treatment recommendations to prevent future osteoporotic fractures.
服用某些药物的癫痫患者有患骨质疏松症和椎骨骨折的风险,而这些骨折通常未被诊断出来。通过使用骨密度扫描中提供的技术,我们观察到许多骨密度处于正常和骨质疏松范围内的受试者中至少有一处骨折。
目的/介绍:慢性使用抗癫痫药物(AED),包括酶诱导剂(苯妥英、苯巴比妥、卡马西平和苯妥英钠)和非酶诱导剂(即丙戊酸),被认为是继发性骨质疏松症的一个原因。椎体压缩性骨折(VF)是最常见的骨质疏松性骨折类型,可能会增加未来髋部、腕部和椎体骨折的风险。在普通人群中,椎体压缩性骨折通常无症状,且诊断不足。本研究的目的是描述慢性使用已知可引起骨质疏松症的 AED 的癫痫男性退伍军人队列中 VF 的患病率。
本研究的队列包括 146 名患有癫痫诊断且慢性使用 AED 的男性退伍军人,这些 AED 已知可引起骨质疏松症(苯巴比妥、苯妥英、卡马西平、苯妥英钠和丙戊酸)。慢性 AED 使用定义为至少接受 AED 治疗 2 年。受试者先前曾在骨质疏松症诊所就诊,并在同一 DXA 成像采集过程中,根据标准椎体骨折评估(VFA)协议,通过双能 X 射线吸收仪(DXA)仪器进行了形态学研究。
平均年龄为 63 岁。低骨密度定义为骨质疏松症或骨量减少,分别为 29%和 43%。我们观察到,在 BMD 正常的受试者中,有 41%至少有一处 VF,在骨量减少的受试者中,有 54%至少有一处 VF,在骨质疏松的受试者中,有 75%至少有一处 VF。
通过在标准骨密度研究之外进行 VFA,我们发现,在慢性接受 AED 治疗且 BMD 处于正常和骨量减少范围内的癫痫患者中,存在大量的压缩性骨折。应将 VFA 或其他成像方法添加到接受 AED 治疗的癫痫患者的骨健康评估中,因为这可能会改变治疗建议,以预防未来的骨质疏松性骨折。